Scientists Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi Win 2025 Nobel Prize in Medicine for Discovering Peripheral Immune Tolerance

Nobel Prize in Immune Tolerance

Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discoveries related to peripheral immune tolerance.

This mechanism is crucial for preventing the immune system from attacking the body's own tissues, thereby avoiding autoimmune diseases.

Sakaguchi first identified regulatory T cells (Tregs) in 1995, which act as the immune system's "security guards" by maintaining self-tolerance.

Brunkow and Ramsdell later discovered that mutations in the Foxp3 gene are linked to severe autoimmune diseases, such as IPEX syndrome, in both mice and humans.

Their combined work has significantly advanced the understanding of immune regulation and has paved the way for new treatments for cancer, autoimmune diseases, and improved transplantation outcomes.

Reporting for this sectionCareers360Free Press JournalWIONLatestLY

2025 Nobel Prize Announcement

The Nobel Prize announcement was made by the Karolinska Institute in Stockholm, marking the first of the 2025 Nobel Prize announcements. The prize includes a gold medal and 11 million Swedish kronor, which will be shared among the three laureates. The award ceremony is scheduled for December 10, the anniversary of Alfred Nobel’s death.

This recognition highlights the critical balance within the immune system and demonstrates the profound impact of basic science on medical treatments benefiting millions worldwide. The discoveries have not only advanced scientific understanding but have also led to the development of new therapies currently in clinical trials.

Reporting for this sectionABC7 ChicagoNewsmakersNGWNYTDW

Advances in Immune Tolerance Research

The research conducted by Brunkow, Ramsdell, and Sakaguchi has established a new field in immunology, focusing on peripheral immune tolerance. This field explores how the immune system distinguishes between harmful pathogens and the body's own cells, a process more intricate than previously thought.

Sakaguchi's identification of regulatory T cells in 1995 challenged the prevailing belief that immune tolerance was solely developed in the thymus. Brunkow and Ramsdell's subsequent discovery of the Foxp3 gene mutation provided a genetic basis for understanding autoimmune diseases, linking it to conditions like IPEX syndrome.

Reporting for this sectionThe Guardian Nigeria NewsThe HinduThe IndependentScientific AmericanThe Straits Times

Advances in Precision Immunotherapy

The impact of these discoveries extends beyond academic research, influencing the development of precision therapies such as CAR-T cell therapy and immune checkpoint modulators. These therapies promise improved treatments for autoimmune conditions and cancer, highlighting the critical balance within the immune system.

The Nobel Assembly at Karolinska Institutet emphasized the importance of these findings in modern precision immunotherapies, which are currently being tested in numerous clinical trials worldwide. This recognition underscores the transformative potential of basic scientific research in addressing complex medical challenges.

Reporting for this sectionMathrubhumi EnglishHouston Public MediaMedical XpressRepublic World